HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Victoria Atkinson Selected Research

Gemcitabine

12/2021First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Victoria Atkinson Research Topics

Disease

60Melanoma (Melanoma, Malignant)
10/2022 - 11/2014
18Neoplasms (Cancer)
01/2022 - 11/2014
6Brain Neoplasms (Brain Tumor)
06/2022 - 01/2017
5Fever (Fevers)
01/2022 - 09/2016
5Neoplasm Metastasis (Metastasis)
10/2021 - 10/2014
5Disease Progression
10/2020 - 09/2016
3Pneumonia (Pneumonitis)
11/2020 - 01/2017
2Infections
11/2018 - 02/2010
2Body Weight (Weight, Body)
11/2017 - 01/2015
2Fatigue
12/2016 - 01/2015
1Lung Neoplasms (Lung Cancer)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Squamous Cell Neoplasms (Squamous Cell Cancer)
12/2021
1Glioma (Gliomas)
12/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2021
1Colitis
11/2020
1Drug-Related Side Effects and Adverse Reactions
11/2020
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
11/2020
1Fibrosis (Cirrhosis)
01/2020
1Acute Tubulointerstitial Nephritis
01/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Papillary Thyroid Cancer
01/2020
1Inflammation (Inflammations)
01/2020
1Endometrial Neoplasms (Endometrial Cancer)
01/2020
1Thyroid Neoplasms (Thyroid Cancer)
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Exanthema (Rash)
01/2019
1Lymphatic Metastasis
01/2019
1Hepatitis B
11/2018
1Melanosis (Freckles)
10/2018
1Adenocarcinoma
06/2018
1Myositis (Idiopathic Inflammatory Myopathies)
05/2018
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Dehydration (Water Stress)
09/2016
1Pruritus (Itching)
01/2015
1Nausea
01/2015
1Peritoneal Neoplasms
01/2015
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2015
1Nevus (Nevi)
10/2014
1Factor XII Deficiency
02/2010
1Gangrene
08/2009
1Thrombosis (Thrombus)
08/2009
1Pyoderma Gangrenosum
08/2009

Drug/Important Bio-Agent (IBA)

15dabrafenibIBA
01/2022 - 10/2014
14trametinibIBA
01/2022 - 10/2014
13IpilimumabIBA
05/2022 - 01/2015
12Immune Checkpoint InhibitorsIBA
06/2022 - 01/2017
11NivolumabIBA
05/2022 - 01/2015
11Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2022 - 11/2014
11pembrolizumabIBA
01/2022 - 01/2017
4VemurafenibIBA
10/2021 - 11/2014
4cobimetinibIBA
10/2021 - 11/2014
3Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2020
3Dacarbazine (DIC)FDA LinkGeneric
11/2020 - 01/2015
3Pharmaceutical PreparationsIBA
01/2019 - 06/2015
2B7-H1 AntigenIBA
01/2022 - 11/2018
2Phosphotransferases (Kinase)IBA
10/2021 - 01/2020
2LigandsIBA
01/2021 - 05/2018
2SteroidsIBA
01/2020 - 01/2017
2PlacebosIBA
01/2020 - 01/2019
2Programmed Cell Death 1 ReceptorIBA
01/2019 - 11/2018
1Proton Pump InhibitorsIBA
05/2022
1cyclopropapyrroloindoleIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
12/2021
1Cisplatin (Platino)FDA LinkGeneric
12/2021
1GemcitabineFDA Link
12/2021
1130-nm albumin-bound paclitaxelIBA
12/2021
1LY3300054IBA
12/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2021
1Toll-Like Receptor 3IBA
01/2021
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1Proteins (Proteins, Gene)FDA Link
11/2020
1spartalizumabIBA
10/2020
1CTLA-4 AntigenIBA
10/2020
1Codon (Codons)IBA
01/2020
1CreatinineIBA
01/2020
1Transaminases (Aminotransferases)IBA
01/2019
1TabletsIBA
11/2017
1tributyl phosphate (TBP)IBA
11/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2017
1AntibodiesIBA
01/2017
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
12/2016
1A 7 (A-7)IBA
09/2016
1Heparin (Liquaemin)FDA LinkGeneric
08/2009

Therapy/Procedure

41Therapeutics
10/2022 - 10/2014
12Immunotherapy
10/2022 - 10/2017
6Drug Therapy (Chemotherapy)
01/2022 - 01/2015
3Radiotherapy
01/2021 - 12/2016
2Neoadjuvant Therapy
10/2022 - 06/2018
2Injections
01/2021 - 11/2020
1Transplantation
01/2021
1Retreatment
10/2020
1Chemoradiotherapy
06/2018
1Intravenous Infusions
11/2017
1Cytoreduction Surgical Procedures
01/2015
1Hyperthermic Intraperitoneal Chemotherapy
01/2015
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2010
1Postoperative Care
02/2010
1Cardiopulmonary Bypass (Heart-Lung Bypass)
02/2010